Dyne Therapeutics, Inc. DYN Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Dyne Therapeutics, Inc.’s reported figures.
The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dyne Therapeutics, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dyne Therapeutics, Inc.'s invested capital?
- Dyne Therapeutics, Inc. (DYN) reported invested capital of $280.63M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s invested capital changed year-over-year?
- Dyne Therapeutics, Inc.'s invested capital increased by 27.5% year-over-year, from $220.05M to $280.63M.
- What is the long-term trend for Dyne Therapeutics, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Dyne Therapeutics, Inc.'s invested capital has grown at a 42.4% compound annual growth rate (CAGR), from $42.32M to $247.96M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).